| 1 | Aksu et al30) | 2021 May | M | 68 | Rt. mammary regionRt. back(T3-T5 dermatomes) | • Hypertension• Dysrhythmia• Anxiety | N/A (2nd shot) | 5 |
| 2 | Bostan et al31) | 2021 Jun | M | 78 | Lt. chest(T3-T4 dermatomes) | • Coronary artery disease• Cerebrovascular accident• Hypertension• Chronic pulmonary obstructive disease• Radical cystectomy and prostatectomy due to bladder cancer | Inactivated vaccine | 5 |
| 3 | Arora et al32) | 2021 Jun | M | 60 | Rt. thigh(L2-L3 dermatomes) | • Type II diabetes mellitus• Hypertension | Inactivated vaccine | 4 |
| 4 | Lee et al33) | 2021 Jul | M | 77 | Mid-abdomenRt. flankRt. mid-back | • Crohn's Disease• Aspergilloma• Psoriasis | Moderna (1st dose) | 4 |
| 5 | M | 56 | Rt. chest | • Atopic Eczema | Moderna (1st dose) | 4 |
| 6 | F | 54 | Lt. backLt. shoulderLt. triceps | • Thyroidectomy• Hysterectomy,• Cholecystectomy• Wide local excision due to melanoma | Moderna (1st dose) | 5 |
| 7 | M | 65 | Lt. axillaLt. shoulderLt. triceps | • Hypertension• Shingles | Pfizer (2nd dose) | 38 |
| 8 | F | 43 | 1) Bump on Rt. neck2) Rt. collarbone & Rt. lower jaw | • Hypertension | Pfizer (2nd dose) | 1) 42) 8 |
| 9 | F | 69 | Lt. axillaLt. upper breast | • Polycythemia vera treated with Jakafi• Hypertension• Dyslipidemia• Osteopenia• Psoriasis• Actinic keratosis• Basal-cell skin cancer• Squamous-cell skin cancer• Vaccinated with Zostavax and Shingrix | Moderna (1st dose) | 4-7 |
| 10 | M | 42 | Scattered blistering | • Chickenpox | Moderna (1st dose) | 21 |
| 11 | F | 47 | T1 dermatome | • Vascular issues to extremities | Moderna (1st dose) | 15 |
| 12 | F | 39 | Rt. backRt. flank | • Hypertension• Diabetes mellitus | Moderna (1st dose) | 5 |
| 13 | M | 74 | Mid-chestRt. arm | • Kidney failure• Anemia• Hypertension• Gout• Heart failure• Atrial fibrillation | Pfizer (2nd dose) | 3 |
| 14 | M | 48 | Lt. flank | • Chickenpox | Pfizer (1st dose) | 12 |
| 15 | F | 68 | Lt. axillaLt. tricepsLt. scapula | • Hypothyroidism• Hypertension• Adrenal fatigue• Chickenpox• Hives from stress• Rubella• Measles | Moderna (1st dose) | 12 |
| 16 | M | 46 | Rt. flank | • None | Pfizer (1st dose) | 9 |
| 17 | F | 60 | Rt. forehead along hairline | • Thyroid cancer• Gout | Moderna (2nd dose) | 26-28 |
| 18 | M | 43 | Rt. flank and back | • Chickenpox | Moderna (1st dose) | 3 |
| 19 | F | 65 | Around and under Rt. eye | • Shingles 10 years prior to current episode• Vaccinated for shingles in 2015 and 2019 | Moderna (1st shot) | 11 |
| 20 | M | 44 | Lt. eyebrow | • None | Pfizer (1st dose) | 5 |
| 21 | F | 37 | Lt. backLt. abdomen | • None | Moderna (1st dose) | 4-5 |
| 22 | M | 69 | Unilateral Rt. back and Rt. arm | • Hypercholesterolemia• Susceptible to poison ivy• Vaccinated for shingles in July 2020 | Moderna (1st dose) | 14 |
| 23 | F | 72 | Lt. armLt. upper backLt. breast | • Hypertension• Rt. breast cancer• Often itchy | Moderna (2nd dose) | 5-6 |
| 24 | Chiu et al34) | 2021 Jul | M | 71 | Lt. T8 dermatome | • None | Moderna (1st shot) | 2 |
| 25 | M | 46 | Lt. T11 dermatome | • None | AZ (1st dose) | 2 |
| 26 | M | 42 | Rt. T10 dermatome | • None | AZ (1st dose) | 7 |
| 27 | Thimmanagari et al35) | 2021 Jul | M | 42 | Lt. foreheadLt. upper eyelidLt. scalpTip of the nose | • Asthma• Chickenpox | J & J | 7 |
| 28 | M | 49 | Rt. forehead(V1 dermatome) | • Bipolar disorder• Schizophrenia• Hyperlipidemia | Moderna (1st dose) | 7 |
| 29 | David et al36) | 2021 Aug | F | 41 | Lt. lower back | • Varicella• Migraine | Moderna | 8 |
| 30 | Eid et al37) | 2021 Sep | M | 79 | Rt. thigh | • Hypertension• Coronary artery disease• Antineutrophilic cytoplasmic antibody-related glomerulonephritis | mRNA vaccine | 6 |
| 31 | Tessas et al38) | 2021 Oct | M | 44 | Lt. upper backLateral and inner side of the Lt. arm(C5-C6 dermatomes) | • Dyslipidemia• Active smoking• Mild varicella | Pfizer (1st shot) | 7 |